Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? — Oct 21st, 2024

Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% gain over the past four weeks. The company’s sole marketed ...

Implied Volatility Surging for Corcept Therapeutics (CORT) Stock Options — Oct 15th, 2024

Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 15, 2024 $12 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...

5 Stocks With Recent Price Strength Amid October Volatility — Oct 11th, 2024

October generally remains volatile on Wall Street. This year, volatility has gripped in U.S. stock markets from the beginning of this month. October’s volatility is expected to persist due to a better-than-expected jobs data for September, expectations of a Fed rate cut in a gradual fash...

Wall Street Analysts See a 43.01% Upside in Corcept (CORT): Can the Stock Really Move This High? — Oct 17th, 2024

Shares of Corcept Therapeutics (CORT) have gained 11.8% over the past four weeks to close the last trading session at $47.27, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the me...

Wall Street Analysts See a 43.01% Upside in Corcept (CORT): Can the Stock Really Move This High? — Oct 17th, 2024

Shares of Corcept Therapeutics (CORT) have gained 11.8% over the past four weeks to close the last trading session at $47.27, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the me...

Wall Street Analysts See a 43.01% Upside in Corcept (CORT): Can the Stock Really Move This High? — Oct 17th, 2024

Shares of Corcept Therapeutics (CORT) have gained 11.8% over the past four weeks to close the last trading session at $47.27, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the me...

Implied Volatility Surging for Corcept Therapeutics (CORT) Stock Options — Oct 15th, 2024

Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 15, 2024 $12 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...

Zacks.com featured highlights include Atour Lifestyle, Vertiv, Corcept Therapeutics, Qifu Technology and ADMA Biologics — Oct 14th, 2024

For Immediate Release Chicago, IL – October 14, 2024 – Stocks in this week’s article are Atour Lifestyle Holdings Ltd. ATAT, Vertiv Holdings Co. VRT, Corcept Therapeutics Inc. CORT, Qifu Technology Inc. QFIN and ADMA Biologics Inc. ADMA. 5 Stocks with Recent Price Strength Amid Oct...

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? — Oct 21st, 2024

Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% gain over the past four weeks. The company’s sole marketed ...

Zacks.com featured highlights include Atour Lifestyle, Vertiv, Corcept Therapeutics, Qifu Technology and ADMA Biologics — Oct 14th, 2024

For Immediate Release Chicago, IL – October 14, 2024 – Stocks in this week’s article are Atour Lifestyle Holdings Ltd. ATAT, Vertiv Holdings Co. VRT, Corcept Therapeutics Inc. CORT, Qifu Technology Inc. QFIN and ADMA Biologics Inc. ADMA. 5 Stocks with Recent Price Strength Amid Oct...

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? — Oct 21st, 2024

Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% gain over the past four weeks. The company’s sole marketed ...

Implied Volatility Surging for Corcept Therapeutics (CORT) Stock Options — Oct 15th, 2024

Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 15, 2024 $12 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...

Zacks.com featured highlights include Corcept Therapeutics, Abercrombie & Fitch and HCI Group — Oct 10th, 2024

For Immediate Release Chicago, IL – October 10, 2024 – Stocks in this week’s article are Corcept Therapeutics Inc. CORT, Abercrombie & Fitch Co. ANF and HCI Group, Inc. HCI. 3 Strong Buy Momentum Stocks as Bull Market Nears 2-Year Mark Entering the fourth quarter of 2024, Wall Str...

5 Stocks With Recent Price Strength Amid October Volatility — Oct 11th, 2024

October generally remains volatile on Wall Street. This year, volatility has gripped in U.S. stock markets from the beginning of this month. October’s volatility is expected to persist due to a better-than-expected jobs data for September, expectations of a Fed rate cut in a gradual fash...

5 Stocks With Recent Price Strength Amid October Volatility — Oct 11th, 2024

October generally remains volatile on Wall Street. This year, volatility has gripped in U.S. stock markets from the beginning of this month. October’s volatility is expected to persist due to a better-than-expected jobs data for September, expectations of a Fed rate cut in a gradual fash...

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? — Oct 21st, 2024

Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% gain over the past four weeks. The company’s sole marketed ...

Zacks.com featured highlights include Atour Lifestyle, Vertiv, Corcept Therapeutics, Qifu Technology and ADMA Biologics — Oct 14th, 2024

For Immediate Release Chicago, IL – October 14, 2024 – Stocks in this week’s article are Atour Lifestyle Holdings Ltd. ATAT, Vertiv Holdings Co. VRT, Corcept Therapeutics Inc. CORT, Qifu Technology Inc. QFIN and ADMA Biologics Inc. ADMA. 5 Stocks with Recent Price Strength Amid Oct...

Implied Volatility Surging for Corcept Therapeutics (CORT) Stock Options — Oct 15th, 2024

Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 15, 2024 $12 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...

Zacks.com featured highlights include Atour Lifestyle, Vertiv, Corcept Therapeutics, Qifu Technology and ADMA Biologics — Oct 14th, 2024

For Immediate Release Chicago, IL – October 14, 2024 – Stocks in this week’s article are Atour Lifestyle Holdings Ltd. ATAT, Vertiv Holdings Co. VRT, Corcept Therapeutics Inc. CORT, Qifu Technology Inc. QFIN and ADMA Biologics Inc. ADMA. 5 Stocks with Recent Price Strength Amid Oct...

Wall Street Analysts See a 43.01% Upside in Corcept (CORT): Can the Stock Really Move This High? — Oct 17th, 2024

Shares of Corcept Therapeutics (CORT) have gained 11.8% over the past four weeks to close the last trading session at $47.27, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the me...

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? — Oct 21st, 2024

Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% gain over the past four weeks. The company’s sole marketed ...

Zacks.com featured highlights include Corcept Therapeutics, Abercrombie & Fitch and HCI Group — Oct 10th, 2024

For Immediate Release Chicago, IL – October 10, 2024 – Stocks in this week’s article are Corcept Therapeutics Inc. CORT, Abercrombie & Fitch Co. ANF and HCI Group, Inc. HCI. 3 Strong Buy Momentum Stocks as Bull Market Nears 2-Year Mark Entering the fourth quarter of 2024, Wall Str...

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? — Oct 21st, 2024

Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% gain over the past four weeks. The company’s sole marketed ...

Wall Street Analysts See a 43.01% Upside in Corcept (CORT): Can the Stock Really Move This High? — Oct 17th, 2024

Shares of Corcept Therapeutics (CORT) have gained 11.8% over the past four weeks to close the last trading session at $47.27, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the me...

Wall Street Analysts See a 43.01% Upside in Corcept (CORT): Can the Stock Really Move This High? — Oct 17th, 2024

Shares of Corcept Therapeutics (CORT) have gained 11.8% over the past four weeks to close the last trading session at $47.27, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the me...

5 Stocks With Recent Price Strength Amid October Volatility — Oct 11th, 2024

October generally remains volatile on Wall Street. This year, volatility has gripped in U.S. stock markets from the beginning of this month. October’s volatility is expected to persist due to a better-than-expected jobs data for September, expectations of a Fed rate cut in a gradual fash...

Wall Street Analysts See a 43.01% Upside in Corcept (CORT): Can the Stock Really Move This High? — Oct 17th, 2024

Shares of Corcept Therapeutics (CORT) have gained 11.8% over the past four weeks to close the last trading session at $47.27, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the me...

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? — Oct 21st, 2024

Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% gain over the past four weeks. The company’s sole marketed ...

5 Stocks With Recent Price Strength Amid October Volatility — Oct 11th, 2024

October generally remains volatile on Wall Street. This year, volatility has gripped in U.S. stock markets from the beginning of this month. October’s volatility is expected to persist due to a better-than-expected jobs data for September, expectations of a Fed rate cut in a gradual fash...

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? — Oct 21st, 2024

Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% gain over the past four weeks. The company’s sole marketed ...

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? — Oct 21st, 2024

Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% gain over the past four weeks. The company’s sole marketed ...

Zacks.com featured highlights include Corcept Therapeutics, Abercrombie & Fitch and HCI Group — Oct 10th, 2024

For Immediate Release Chicago, IL – October 10, 2024 – Stocks in this week’s article are Corcept Therapeutics Inc. CORT, Abercrombie & Fitch Co. ANF and HCI Group, Inc. HCI. 3 Strong Buy Momentum Stocks as Bull Market Nears 2-Year Mark Entering the fourth quarter of 2024, Wall Str...

Wall Street Analysts See a 43.01% Upside in Corcept (CORT): Can the Stock Really Move This High? — Oct 17th, 2024

Shares of Corcept Therapeutics (CORT) have gained 11.8% over the past four weeks to close the last trading session at $47.27, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the me...

Implied Volatility Surging for Corcept Therapeutics (CORT) Stock Options — Oct 15th, 2024

Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 15, 2024 $12 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? — Oct 21st, 2024

Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% gain over the past four weeks. The company’s sole marketed ...

Zacks.com featured highlights include Atour Lifestyle, Vertiv, Corcept Therapeutics, Qifu Technology and ADMA Biologics — Oct 14th, 2024

For Immediate Release Chicago, IL – October 14, 2024 – Stocks in this week’s article are Atour Lifestyle Holdings Ltd. ATAT, Vertiv Holdings Co. VRT, Corcept Therapeutics Inc. CORT, Qifu Technology Inc. QFIN and ADMA Biologics Inc. ADMA. 5 Stocks with Recent Price Strength Amid Oct...

Zacks.com featured highlights include Atour Lifestyle, Vertiv, Corcept Therapeutics, Qifu Technology and ADMA Biologics — Oct 14th, 2024

For Immediate Release Chicago, IL – October 14, 2024 – Stocks in this week’s article are Atour Lifestyle Holdings Ltd. ATAT, Vertiv Holdings Co. VRT, Corcept Therapeutics Inc. CORT, Qifu Technology Inc. QFIN and ADMA Biologics Inc. ADMA. 5 Stocks with Recent Price Strength Amid Oct...

Zacks.com featured highlights include Atour Lifestyle, Vertiv, Corcept Therapeutics, Qifu Technology and ADMA Biologics — Oct 14th, 2024

For Immediate Release Chicago, IL – October 14, 2024 – Stocks in this week’s article are Atour Lifestyle Holdings Ltd. ATAT, Vertiv Holdings Co. VRT, Corcept Therapeutics Inc. CORT, Qifu Technology Inc. QFIN and ADMA Biologics Inc. ADMA. 5 Stocks with Recent Price Strength Amid Oct...

Zacks.com featured highlights include Corcept Therapeutics, Abercrombie & Fitch and HCI Group — Oct 10th, 2024

For Immediate Release Chicago, IL – October 10, 2024 – Stocks in this week’s article are Corcept Therapeutics Inc. CORT, Abercrombie & Fitch Co. ANF and HCI Group, Inc. HCI. 3 Strong Buy Momentum Stocks as Bull Market Nears 2-Year Mark Entering the fourth quarter of 2024, Wall Str...

5 Stocks With Recent Price Strength Amid October Volatility — Oct 11th, 2024

October generally remains volatile on Wall Street. This year, volatility has gripped in U.S. stock markets from the beginning of this month. October’s volatility is expected to persist due to a better-than-expected jobs data for September, expectations of a Fed rate cut in a gradual fash...

Implied Volatility Surging for Corcept Therapeutics (CORT) Stock Options — Oct 15th, 2024

Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 15, 2024 $12 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...

5 Stocks With Recent Price Strength Amid October Volatility — Oct 11th, 2024

October generally remains volatile on Wall Street. This year, volatility has gripped in U.S. stock markets from the beginning of this month. October’s volatility is expected to persist due to a better-than-expected jobs data for September, expectations of a Fed rate cut in a gradual fash...

Implied Volatility Surging for Corcept Therapeutics (CORT) Stock Options — Oct 15th, 2024

Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 15, 2024 $12 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...

Wall Street Analysts See a 43.01% Upside in Corcept (CORT): Can the Stock Really Move This High? — Oct 17th, 2024

Shares of Corcept Therapeutics (CORT) have gained 11.8% over the past four weeks to close the last trading session at $47.27, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the me...

Implied Volatility Surging for Corcept Therapeutics (CORT) Stock Options — Oct 15th, 2024

Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 15, 2024 $12 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? — Oct 21st, 2024

Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% gain over the past four weeks. The company’s sole marketed ...

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? — Oct 21st, 2024

Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% gain over the past four weeks. The company’s sole marketed ...

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? — Oct 21st, 2024

Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.3% gain over the past four weeks. The company’s sole marketed ...

Zacks.com featured highlights include Atour Lifestyle, Vertiv, Corcept Therapeutics, Qifu Technology and ADMA Biologics — Oct 14th, 2024

For Immediate Release Chicago, IL – October 14, 2024 – Stocks in this week’s article are Atour Lifestyle Holdings Ltd. ATAT, Vertiv Holdings Co. VRT, Corcept Therapeutics Inc. CORT, Qifu Technology Inc. QFIN and ADMA Biologics Inc. ADMA. 5 Stocks with Recent Price Strength Amid Oct...

5 Stocks With Recent Price Strength Amid October Volatility — Oct 11th, 2024

October generally remains volatile on Wall Street. This year, volatility has gripped in U.S. stock markets from the beginning of this month. October’s volatility is expected to persist due to a better-than-expected jobs data for September, expectations of a Fed rate cut in a gradual fash...